Almost a third of people who bought their own health insurance last year will get rebates averaging $127 because of a requirement in the federal health care law, according to a new report from the Kaiser Family Foundation.
But the percentage of consumers eligible for rebates varies widely by state, and by insurer within each state, the analysis found. In Texas, for instance, 92 percent of individual insurance customers are expected to get rebates. But no insurers expect to issue rebates in Hawaii.
When averaged by state, the report said, the largest per-person rebates would be paid to individuals in Alaska ($305) and Maryland ($294). But the expected rebates would be just $1 in Vermont and New Mexico — which is so low that under the rules, insurers probably won’t have to issue them.
Read the full story: http://hcp.lv/KgxeQl
Source: The New York Times
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More